sinc
first
shown
interfer
viral
replic
within
host
cell
becom
one
best
studi
cytokin
benefici
effect
well
appreci
numer
viral
experiment
model
induc
antivir
state
type
interferon
one
success
antivir
treatment
therapeut
clinic
use
chronic
hepat
c
infect
viral
infect
somat
cell
result
earli
synthesi
product
special
cell
call
plasmacytoid
dendrit
cell
pdc
major
produc
mediat
system
respons
follow
viral
infect
primari
role
limit
initi
viral
replic
facilit
subsequ
adapt
immun
respons
multifunct
cytokin
posit
influenc
cell
innat
adapt
immun
therefor
consid
bridg
link
innat
adapt
immun
review
except
chronic
viral
infect
studi
agre
protect
acut
viral
infect
clearli
demonstr
knockout
mous
studi
mice
defici
function
receptor
highli
suscept
viral
infect
influenza
viru
encephalit
flavivirus
schmallenberg
viru
lymphocyt
choriomening
viru
besid
antivir
respons
bacteri
infect
also
lead
induct
synthesi
howev
contrast
role
respons
viral
infect
effect
host
case
bacteria
may
either
benefici
detriment
tabl
precis
mechan
behind
dualist
effect
bacteria
fulli
understood
recent
studi
provid
insight
suppress
antibacteri
immun
exampl
tele
et
report
vitro
induct
human
monocyt
respons
mycobacterium
lepra
promot
product
cytokin
togeth
synergist
limit
product
type
ii
ifn
import
effector
cytokin
bacteri
infect
mous
model
francisella
tularensi
listeria
monocytogen
infect
shown
suppress
gamma
delta
respons
subsequ
neutrophil
recruit
neutrophil
play
import
role
antibacteri
immun
review
highli
detriment
host
f
tularemia
infect
regardless
differ
report
mechan
clear
enhanc
host
suscept
certain
bacteri
pathogen
suppress
host
antibacteri
immun
live
viral
infect
mous
model
caus
system
partial
lymphocyt
activ
character
increas
express
activ
marker
receptor
vast
major
lymphocyt
undergo
partial
activ
within
h
viral
infect
cell
surfac
marker
express
return
normal
around
day
recent
report
suggest
possibl
biolog
role
phenomenon
shown
earli
activ
temporarili
retain
lymphocyt
secondari
lymphoid
organ
presum
promot
interact
lymphocyt
cell
concurr
respiratori
infect
common
among
young
children
elderli
epidemiolog
studi
influenza
pandem
identifi
respiratori
virus
coronaviru
human
bocaviru
respiratori
syncyti
viru
human
rhinovirus
consist
epidemiolog
studi
mous
model
viral
diseas
show
enhanc
suscept
secondari
unrel
viral
episod
follow
primari
viral
infect
biolog
role
partial
lymphocyt
activ
primari
infect
yet
understood
consequ
refractori
period
respons
secondari
infect
attract
attent
due
clinic
implic
show
unrel
secondari
adenoviru
infect
follow
primari
semliki
forest
viru
sfv
infect
fail
trigger
partial
lymphocyt
activ
durat
day
infect
due
exhaust
found
level
detect
limit
day
secondari
viral
infect
host
regain
capac
mount
respons
day
primari
viral
infect
thu
like
exhaust
respons
heighten
suscept
secondari
viral
infect
model
examin
synergist
consequ
respiratori
pathogen
predominantli
concern
combin
viral
bacteri
pathogen
larg
due
inform
gain
devast
spanish
influenza
pandem
major
death
due
bacteri
subsequ
bacteri
infect
case
swine
flu
pandem
influenza
episod
admit
intens
care
unit
worldwid
due
complic
caus
bacteri
case
staphylococcu
aureu
streptococcu
pneumonia
commonli
isol
bacteri
pathogen
pathogen
colon
upper
respiratori
tract
nasopharyng
caviti
therefor
hypothes
influenza
infect
allow
outgrowth
colon
pneumonia
aureu
result
mucos
secondari
infect
occur
frequent
day
primari
viral
infect
thu
suggest
transient
immunosuppress
may
respons
bacteri
outgrowth
mechan
propos
synerg
influenza
pneumonia
suggest
antivir
respons
elicit
primari
influenza
viru
infect
enhanc
suscept
host
secondari
bacteri
challeng
via
suppress
antibacteri
immun
recent
mathemat
model
epidemiolog
data
influenza
pandem
shown
posit
correl
mycobacterium
tuberculosi
influenza
death
tuberculosi
clinic
import
bacteri
pathogen
latent
infect
world
popul
neg
effect
tuberculosi
infect
repeatedli
shown
howev
except
highli
virul
strain
tuberculosi
gener
induc
strong
respons
despit
possess
receptor
tlr
agonist
cpg
motif
potent
induc
phenomenon
recent
explain
name
detect
mycobacteri
lipoprotein
inhibit
signal
pathway
via
deplet
signal
molecul
kinas
therebi
turn
suppress
product
tuberculosi
infect
neg
regul
respons
tuberculosi
infect
like
benefici
host
limit
harm
effect
inhibitori
mechan
may
also
play
posit
role
bacteri
infect
recogn
wide
rang
bacteri
pathogen
interest
signal
impair
synthesi
turn
explain
influenza
viru
mice
impair
bacteri
control
manner
influenza
viru
gener
multipl
ligand
pattern
recognit
receptor
viral
replic
cycl
includ
dsrna
agonist
ssrna
agonist
thu
influenza
viru
infect
overrid
inhibit
respons
mice
signal
induc
respons
ultim
result
outgrowth
tuberculosi
find
provid
answer
risk
influenza
death
higher
among
patient
tuberculosi
patient
influenza
pandem
recent
studi
focus
mechan
primari
viral
infect
render
host
vulner
sequel
bacteri
infect
sever
form
rare
seen
viru
highli
virul
spanish
influenza
viru
fact
accord
centr
diseas
control
prevent
fatal
case
patient
influenza
bacteri
primari
viral
infect
highli
pathogen
difficult
ascertain
whether
increas
suscept
due
suppress
antibacteri
immun
consequ
viral
patholog
hypothes
sever
form
except
rule
case
less
virul
virus
primari
infect
lead
sever
secondari
bacteri
patholog
thu
exist
immun
mechan
limit
secondari
current
understand
biolog
benefici
essenti
recov
acut
viral
infect
may
detriment
host
fight
bacteri
pathogen
also
know
previou
studi
report
other
defici
consequ
exhaust
occur
primari
viral
infect
host
render
suscept
secondari
unrel
viral
infect
transient
period
exhaust
base
observ
hypothes
host
evolv
neg
feedback
loop
mechan
limit
product
rapid
transient
render
host
less
suscept
opportunist
bacteri
infect
preval
secondari
unrel
viru
infect
transient
defici
benefit
host
lower
resist
common
secondari
bacteri
infect
fig
support
hypothesi
exhaust
like
evolutionarili
appear
consequ
primari
viral
infect
other
shown
case
adenovirus
alphavirus
orthomyxovirus
murin
cytomegaloviru
lymphocyt
choriomening
viru
evolutionari
perspect
must
strong
select
advantag
transient
exhaust
respons
primari
viral
infect
occur
thu
reason
specul
evolutionari
advantag
neg
feedback
regul
suppress
immun
respons
detriment
secondari
bacteri
infect
shown
previous
explor
influenza
viruss
pneumonia
model
secondari
challeng
either
viru
bacteria
peak
respons
highli
lethal
increas
lethal
attribut
would
interest
find
whether
outcom
experi
would
differ
mice
undergo
primari
viru
infect
challeng
bacteri
pathogen
time
exhaust
day
thu
provid
evid
hypothesi
would
requir
establish
correl
strength
respons
exhaust
sever
secondari
bacteri
challeng
time
cours
bacteri
infect
primari
viru
infect
andor
poli
c
treatment
would
provid
answer
question
poli
c
synthet
analogu
rna
mimic
rna
viral
infect
would
elimin
potenti
unrel
patholog
affect
secondari
bacteri
patholog
shown
poli
mice
mount
respons
render
host
transient
suscept
bacteri
infect
evalu
sever
bacteri
growth
morbid
mortal
establish
whether
exhaust
amelior
secondari
bacteri
patholog
poli
experiment
group
elimin
potenti
unknown
complic
somewhat
surpris
wide
known
phenomenon
refractori
period
viral
infect
yet
investig
consequ
host
suscept
bacteri
infect
given
potenti
clinic
implic
known
detriment
consequ
refractori
period
secondari
viral
infect
name
heighten
suscept
somewhat
hard
understand
evolutionari
term
unless
exist
overrid
rational
may
well
turn
protect
potenti
lethal
bacteri
infect
control
absenc
investig
caus
impair
respons
follow
viral
infect
pdc
princip
secretor
prevail
hypothesi
impair
centr
pdc
pdc
induc
produc
larg
amount
primari
antivir
respons
either
deplet
mechan
nk
cytotox
induc
matur
replac
haematopoesi
acquir
transient
state
unrespons
paralysi
report
experi
use
vitro
stimul
vivo
viral
infect
although
mous
model
use
avirul
sfv
observ
quantit
reduct
pdc
other
report
signific
decreas
number
pdc
soon
acut
persist
viral
infect
consist
anim
data
human
patient
infect
hepat
b
viru
hbv
hepat
c
viru
hcv
hiv
decreas
number
circul
pdc
addit
patient
hcv
infect
receiv
therapi
exhibit
decreas
number
pdc
blood
compar
untreat
control
thu
strong
neg
correl
exist
quantiti
respons
pdc
number
recent
studi
swiecki
et
shown
pdc
deplet
system
viral
infect
occur
manner
upregul
express
bid
bim
noxa
bax
downregul
besid
quantit
chang
qualit
differ
pdc
also
document
pdc
isol
mice
undergo
exhaust
unabl
produc
respons
cpg
agonist
treatment
ex
vivo
interestingli
function
defect
pdc
limit
product
synthesi
secret
cytokin
impair
collect
like
inabl
host
mount
respons
refractori
period
secondari
challeng
due
pdc
intrins
defect
product
overal
reduct
pdc
number
consequ
vastli
reduc
output
may
render
host
less
suscept
secondari
bacteri
infect
research
viralbacteri
recent
year
becom
much
fashion
due
potenti
clinic
signific
studi
focus
understand
viral
infect
caus
heighten
suscept
subsequ
bacteri
infect
much
less
attent
direct
understand
host
evolv
mechan
enhanc
resist
secondari
bacteri
infect
evid
present
support
hypothesi
inhibit
product
mechan
host
reduc
suscept
bacteri
infect
recoveri
primari
viru
infect
